公开(公告)号：US20240190890A1

公开(公告)日：2024-06-13

申请号：US18495004

申请日：2023-10-26

Applicant: Bristol-Myers Squibb Company ,  Celgene Corporation

Inventor： Xirui Hu ,  Lixin Qiao ,  Boris Seletsky ,  Matthew Patton ,  Min Cao ,  Farid van der Mei ,  Guobin Miao ,  Ivar McDonald ,  Carolyn Dzierba

IPC: C07D495/14

CPC classification number: C07D495/14

Abstract: The present invention provides compounds, compositions thereof, and methods of using the MK2 inhibitors of the Formula: